The Bundesanstalt für Materialforschung und -prüfung (BAM) is developing a more sustainable process to produce active pharmaceutical ingredients in a major EU project: The pilot project is intended to demonstrate the advantages of mechanochemistry…
ERC Starting Grants are among Europe’s highest honors. Once again, six early-career scientists at Charité – Universitätsmedizin Berlin, whose research groups are based at Charité, the Berlin Institute of Health at Charité (BIH), the Max Delbrück…
The mammalian genome contains retroviral sequences that are in an undead but mostly “harmless” state. An international research team recently discovered how some of these retroviral gene fragments affect embryonic cells if they are unleashed.…
Every person has an individual chemical fingerprint. The composition of small molecules in the blood, such as fats or sugars, determines how our body reacts to external influences, which diseases we are susceptible to and how severe an illness will…
Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, today announced the…
Christiane von der Eltz was appointed to the Executive Board of BERLIN-CHEMIE on June 1 of this year and is responsible for the Pharma Germany division. The qualified pharmacist brings with her a wealth of experience in the pharmaceutical industry.…
The glass ceiling in the healthcare sector in the capital region is getting thinner. More and more women are finding their way into leadership positions. In order to reduce the inequalities that still exist further, stakeholders in the healthcare…
Takeda, the global biopharmaceutical company, has a history of more than 240 years rich in tradition and always characterized by further development and innovation. In Germany, however, the focus of Takeda is not only on shaping progress in the…
After two years of intensive renovation work, the new location of Charité BIH Innovation (CBI) - the joint technology transfer of Charité and BIH - has opened on October 12. Covering a total of 2,500 m2 spread over four floors, the modern, expanded…
Reverse Clinical Engineering® is now available to oncologists and cancer patients in Saudi Arabia, the Middle East, and North Africa. ASC Oncology proudly announces new partnership with Tamer Group.
